This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Gastroenterology is a branch of medicine that focuses on the diagnosis and treatment of disorders affecting the gastrointestinal (GI) tract. Evidence based medicine (EBM) has become increasingly important in this field, with practitioners relying on the best available research to inform their clinical decisions. EBM is a systematic approach to medical practice that combines the best available evidence with clinical expertise, patient values, and other factors. This evidence can include medical literature, expert opinion, and patient experience. EBM allows practitioners to make decisions based on the best available evidence and to provide the most effective care possible to their patients. In gastroenterology, EBM is particularly important as it allows practitioners to make better decisions about diagnosis, treatment, and management of GI conditions. For example, EBM can help practitioners to distinguish between conditions that may require treatment and those that can be managed through lifestyle changes. It can also help to identify the most effective medications and treatments for particular conditions. EBM also helps to ensure that the latest research is being taken into account in the development of new treatments and guidelines. This helps to ensure that the treatments and guidelines are based on the best available evidence, rather than simply relying on expert opinion. Finally, EBM is also useful for patient education, allowing practitioners to provide their patients with evidence-based information about their condition and its management. This helps to ensure that patients are properly informed about their condition and the treatments available to them. Overall, EBM is an important tool for gastroenterologists, allowing them to make better decisions, develop new treatments and guidelines, and provide their patients with evidence-based information. This helps to ensure that the care they provide is of the highest quality, and that their patients receive the best available treatment.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States